NCAM1 and acute myeloid leukemia: The study of T cells (CD3+ CD56−) showed no statistically significant changes in the expression of LAG-3 (48.58 ± 14.97 in AML and 56.80 ± 14.10 in healthy donors) (Fig. 2a).